Corbus Pharmaceuticals Holdings, Inc. · NASDAQ:CRBP

Citadel Advisors LLC reported a 5.30% stake in Corbus Pharmaceuticals Holdings, Inc. (Schedule 13G)

Event Nov 4, 2025 · Filed Nov 12, 2025

Citadel Advisors LLC reported a 5.30% stake in Corbus Pharmaceuticals Holdings, Inc., 980,610 shares, as a passive investor on Nov 4, 2025. Filed Nov 12, 2025 (Schedule 13G).

Stake
5.30%
Shares
980,610
Intent
Passive
What changed
Crossed above 5%
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Advisors LLC4.70%873,313
Citadel Advisors Holdings LP4.70%873,313
Citadel GP LLC4.70%873,313
Citadel Securities LLC0.60%107,297
Citadel Securities Group LP0.60%107,297
Citadel Securities GP LLC0.60%107,297
Kenneth Griffin5.30%980,610

Source

View original at SEC

Related